Studies on regulation of the human gene for insulin-like growth factorbinding protein-1 /

Insulin, glucocorticoids and glucagon (cAMP) interact to

Bibliographic Details
Main Author: Suwanichkul, Adisak, 1955-
Format: Thesis Book
Language:English
Published: [Place of publication not identified] : [publisher not identified] ; 1994.
Subjects:
Online Access:http://proxy.library.tamu.edu/login?url=http://proquest.umi.com/pqdweb?did=741965911&sid=1&Fmt=2&clientId=2945&RQT=309&VName=PQD
Description
Summary:Insulin, glucocorticoids and glucagon (cAMP) interact to
regulate transcription of many hepatic genes, and this
regulation is often crucial to the survival of the indi
vidual. The studies presented here begin to investigate the
multihormonal regulation of the human gene for insulin-like
growth factor binding protein-1 (IGFBP-1) , a protein which
helps to regulate serum glucose levels. Basal IGFBP-1
expression in HEP G2 he-catoma cells depends on a proximal
promoter element that binds hepatic nuclear factor I (.HNFl)
. Cotransfection of HEP G2 and HeLa cells with IGFBP-1
promoter constructs and HNF1 expression vectors indicated
that only an HNF1 form containing the -Lransacti-vation
domain could stimulate IGFBP-1 promoter activity. This
suggests that HNFI is required for basal IGFBP-1
transcription. IGFBP-1 transcription rises with
glucocorticoids and cAMP, and falls with insulin. Recent
studies suggest -that these hormones regulate transcription
by working through DNA elements located in the -oroximal
IGFBP-1 -oromoter. Constructs containing IGFBP-1 T)romoter
mutations were used in transfection and DNase I protection
assays to show a) much of the cAMP response is mediated by
the region between -269 and -246 base pairs (bp) 5 to the
transcription start site, which has a sequence similar to
known cAMP response elements (CREs); and b) binding of CPEB,
a protein known to confer CAMP effects,, to mutations of this
region correlated with response of these mutations to CAMP.
These data suggest that this region is a CRE confering CAMP
responsiveness to the IGFBP-1 promoter. IGFBP-1 promoter
mutations were also used to identify an element between -140
and -103 bp which confered the inhibitory effect of insulin.
Gel mobility-shift assays show that high mobility group
proteins I/Y, IRE binding protein, HNF-3(x and HNF-38, were
all able to bind specifically to this IGFBP1 IRE. Similarly,
promoter mutations and DNase I protection assays identified
two glucocorticoid response elements (GREs), located within
the first 200 bp of the IGFBP-1 promoter, which act
cooperatively to confer glucocorticoids effects. Additional
studies found that the IRE identified above a) confers the
entire inhibitory effect of insulin on both basal and
glucocorticoid-stimulated activity of the IGFBP-1 promoter;
and b) this IRE is essential for maximal glucocorticoid-
stimulated activity.
Item Description:Vita.
"Major Subject: Veterinary Microbiology".
In title, numerals are used.
Physical Description:ix, 98 leaves : illustrations ; 28 cm.
Issued also on microfiche from University Microfilms Inc.
Bibliography:Includes bibliographical references.